Sport
|
|
Rosehill Closure
|
|
needle
|
1 |
429 |
0 |
07/12/23 |
07/12/23 |
Sport
|
1
|
429
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: 2023 Corporate Governance Statement
|
|
needle
|
22 |
6.4K |
1 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
22
|
6.4K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: 2023 Corporate Governance Statement
|
|
needle
|
22 |
6.4K |
7 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
22
|
6.4K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Examples of Suspicious Pricing Action
|
|
needle
|
273 |
89K |
7 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
273
|
89K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
needle
|
103 |
38K |
14 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
103
|
38K
|
14
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
needle
|
103 |
38K |
8 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
103
|
38K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Comparisions other Drug Companies
|
|
needle
|
6 |
2.5K |
10 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
6
|
2.5K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
needle
|
103 |
38K |
8 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
103
|
38K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
top 20
|
|
needle
|
27 |
10K |
3 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
27
|
10K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Comparisions other Drug Companies
|
|
needle
|
6 |
2.5K |
5 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
6
|
2.5K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Comparisions other Drug Companies
|
|
needle
|
6 |
2.5K |
4 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
6
|
2.5K
|
4
|
|
ASX - By Stock
|
KZA |
Comparisions other Drug Companies
|
|
needle
|
6 |
2.5K |
5 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
6
|
2.5K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
needle
|
42 |
13K |
4 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
42
|
13K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Notification regarding unquoted securities - KZA
|
|
needle
|
20 |
5.0K |
3 |
23/07/23 |
23/07/23 |
ASX - By Stock
|
20
|
5.0K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Notification regarding unquoted securities - KZA
|
|
needle
|
20 |
5.0K |
9 |
23/07/23 |
23/07/23 |
ASX - By Stock
|
20
|
5.0K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
needle
|
103 |
38K |
7 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
103
|
38K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
GBM PAXALISIB ESMO 09/09/2022
|
|
needle
|
14 |
5.2K |
0 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
14
|
5.2K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
GBM PAXALISIB ESMO 09/09/2022
|
|
needle
|
14 |
5.2K |
6 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
14
|
5.2K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
GBM PAXALISIB ESMO 09/09/2022
|
|
needle
|
14 |
5.2K |
4 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
14
|
5.2K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
GBM PAXALISIB ESMO 09/09/2022
|
|
needle
|
14 |
5.2K |
7 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
14
|
5.2K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
needle
|
103 |
38K |
7 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
103
|
38K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
needle
|
103 |
38K |
10 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
103
|
38K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Proposed issue of securities - KZA
|
|
needle
|
10 |
3.0K |
0 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
10
|
3.0K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Proposed issue of securities - KZA
|
|
needle
|
10 |
3.0K |
2 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
10
|
3.0K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Proposed issue of securities - KZA
|
|
needle
|
10 |
3.0K |
5 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
10
|
3.0K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
needle
|
42 |
13K |
5 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
42
|
13K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change in substantial holding
|
|
needle
|
2 |
891 |
1 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
2
|
891
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
needle
|
42 |
13K |
3 |
08/07/23 |
08/07/23 |
ASX - By Stock
|
42
|
13K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
News: KZA Kazia's Paxalisib Receives Fast Track Designation From FDA For Treatment Of Solid Tumor...
|
|
needle
|
14 |
4.3K |
7 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
14
|
4.3K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
News: KZA Kazia's Paxalisib Receives Fast Track Designation From FDA For Treatment Of Solid Tumor...
|
|
needle
|
14 |
4.3K |
4 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
14
|
4.3K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
needle
|
103 |
38K |
0 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
103
|
38K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
needle
|
103 |
38K |
3 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
103
|
38K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
needle
|
103 |
38K |
6 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
103
|
38K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
needle
|
103 |
38K |
8 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
103
|
38K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
needle
|
2.0K |
620K |
7 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
2.0K
|
620K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Update and Corporate Presentation
|
|
needle
|
27 |
7.9K |
6 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
27
|
7.9K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Update and Corporate Presentation
|
|
needle
|
27 |
7.9K |
9 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
27
|
7.9K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Update and Corporate Presentation
|
|
needle
|
27 |
7.9K |
9 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
27
|
7.9K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
needle
|
34 |
11K |
6 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
34
|
11K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
needle
|
34 |
11K |
3 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
34
|
11K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
needle
|
34 |
11K |
1 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
34
|
11K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
needle
|
34 |
11K |
5 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
34
|
11K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
needle
|
34 |
11K |
9 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
34
|
11K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
needle
|
23 |
6.9K |
6 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
23
|
6.9K
|
6
|
|
ASX - By Stock
|
WAK |
Re:
Ann: WAK Investor Presentation
|
|
needle
|
36 |
12K |
0 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
36
|
12K
|
0
|
|
ASX - By Stock
|
WAK |
Re:
Ann: WAK Investor Presentation
|
|
needle
|
36 |
12K |
0 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
36
|
12K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
needle
|
34 |
11K |
0 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
34
|
11K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
needle
|
34 |
11K |
0 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
34
|
11K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
needle
|
34 |
11K |
1 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
34
|
11K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
needle
|
34 |
11K |
1 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
34
|
11K
|
1
|
|